TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company

Transcenta, biologics, antibody

TRANSCENTA HOLDING - A global Fully Integrated Biotherapeutics Company

contact 中文

WHO WE ARE

Transcenta is a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D, regulatory affairs and manufacturing.

At Transcenta, we focus on helping patients around the world by employing cutting-edge technology to discover and deliver high quality innovative biologics at affordable price.

Transcenta

SHAPED
BY INTEGRATION

Discovery

Employing a unique antibody generation platform based on Immune Tolerance Breaking Technology, our seasoned discovery team can generate and optimize therapeutic candidate leads with differentiated biological profile and enhanced druggability attributes.

Process Development

With a team of about 80 people experienced in various aspects of process development, we can leverage both classical fed-batch and perfusion-based continuous bioprocessing technologies to enable fast-to-IND and fast-to-market process development.

Clinical Development

We take leadership position and work with KOLs and investigators as well as partners in creating a discipline around the clinical innovation to ensure conducting higher quality of clinical trials with speed and agility.

Manufacturing

Equipped with a flexible modular manufacturing facility and advanced next-generation perfusion bioprocessing platform, we are able to significantly accelerate process development and reduce the cost of manufacturing.